• Immunohistochemical analysis of paraffin-embedded human liver cancer. 1, Antibody was diluted at 1:200 (4°C overnight). 2, Tris-EDTA, pH9.0 was used for antigen retrieval. 3, Secondary antibody was diluted at 1:200 (room temperature, 45min).

Anti-Cleaved-MMP21-Ser145 antibody (144-145) (STJA0005892)

SKU:
STJA0005892

Current Stock:
Host: Rabbit
Applications: WB/IHC
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Cleaved-Matrix metalloproteinase-21-Ser145 (144-145) is suitable for use in Western Blot and Immunohistochemistry research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
IHC-p 1:50-300
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: MMP21
Gene ID: 118856
Uniprot ID: MMP21_HUMAN
Immunogen Region: 144-145
Specificity: This antibody detects endogenous levels of Human, Mouse MMP21 (Cleaved-Ser145, protein was cleaved amino acid sequence between 144-145 )
Immunogen: Synthesized peptide derived from human MMP21 (Cleaved-Ser145)
Post Translational Modifications The precursor is cleaved by a furin endopeptidase.
Function Plays a specialized role in the generation of left-right asymmetry during embryogenesis. May act as a negative regulator of the NOTCH-signaling pathway. Cleaves alpha-1-antitrypsin.
Protein Name Matrix Metalloproteinase-21
Mmp-21
Cellular Localisation Secreted
Alternative Antibody Names Anti-Matrix Metalloproteinase-21 antibody
Anti-Mmp-21 antibody
Anti-MMP21 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance